SEC Form 4 · accession 0001127602-18-016509
Elevance Health, Inc. · ELV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian T Griffin
Officer — EVP & CEO, IngenioRx
Period of report
May 3, 2018
Accepted (ET)
May 7, 2018 · 4:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001156039
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 3, 2018 | M | 9,756 | $61.88 | A | 25,619 | D | |
| Common Stock | May 3, 2018 | M | 7,489 | $146.93 | A | 33,108 | D | |
| Common Stock | May 3, 2018 | M | 14,830 | $89.44 | A | 47,938 | D | |
| Common Stock | May 3, 2018 | M | 4,478 | $152.78 | A | 52,416 | D | |
| Common Stock | May 3, 2018 | M | 16,232 | $131.80 | A | 68,648 | D | |
| Common Stock | May 3, 2018 | M | 6,636 | $166.97 | A | 75,284 | D | |
| Common StockF1 | May 3, 2018 | S | 54,497 | $224.32 | D | 20,787 | D | |
| Common StockF2 | May 3, 2018 | S | 4,924 | $225.35 | D | 15,863 | D | |
| Common Stock | holding | — | — | — | 2,245 | I | 2016 GRAT Trust | |
| Common Stock | holding | — | — | — | 17,767 | I | 2017 GRAT I Trust | |
| Common Stock | holding | — | — | — | 17,767 | I | 2017 GRAT II Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F3 | $61.88 | May 3, 2018 | M | 9,756 | D | — | Mar 1, 2020 | Common Stock | 9,756 | 0 | D |
| Employee Stock Option (Right to Buy)F4 | $146.93 | May 3, 2018 | M | 7,489 | D | — | Mar 2, 2025 | Common Stock | 7,489 | 0 | D |
| Employee Stock Option (Right to Buy)F5 | $89.44 | May 3, 2018 | M | 14,830 | D | — | Mar 3, 2021 | Common Stock | 14,830 | 0 | D |
| Employee Stock Option (Right to Buy)F6 | $152.78 | May 3, 2018 | M | 4,478 | D | — | Aug 3, 2025 | Common Stock | 4,478 | 896 | D |
| Employee Stock Option (Right to Buy)F7 | $131.80 | May 3, 2018 | M | 16,232 | D | — | Mar 1, 2026 | Common Stock | 16,232 | 8,116 | D |
| Employee Stock Option (Right to Buy)F8 | $166.97 | May 3, 2018 | M | 6,636 | D | — | Mar 1, 2027 | Common Stock | 6,636 | 13,272 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $224.13 to $225.10. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2This transaction was executed in multiple trades at prices ranging from $225.15 to $225.49. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3The option represents a right to purchase a total of 9,756 shares, and is exercisable in six semi-annual installments of 1,626 shares each, beginning on September 1, 2013, which is the six-month anniversary of the option grant date.
- F4The option represents a right to purchase a total of 7,489 shares, and is exercisable in five semi-annual installments of 1,248 shares each and one installment of 1,249 shares, beginning on September 2, 2015, which is the six-month anniversary of the option grant date.
- F5The option represents a right to purchase a total of 14,830 shares, and is exercisable in six semi-annual installments, with two installments of 2,471 shares each and four installments of 2,472 shares each, beginning on September 3, 2014, which is the six-month anniversary of the option grant date.
- F6The option represents a right to purchase a total of 5,374 shares, and is exercisable in six semi-annual installments, with two installments of 895 shares each and four installments of 896 shares each, beginning on February 3, 2016, which is the six-month anniversary of the option grant date.
- F7The option represents a right to purchase a total of 24,348 shares, and is exercisable in six semi-annual installments of 4,058 shares each, beginning on September 1, 2016, which is the six-month anniversary of the option grant date.
- F8The option represents a right to purchase a total of 19,908 shares, and is exercisable in six semi-annual installments of 3,318 shares each, beginning on September 1, 2017, which is the six-month anniversary of the option grant date.